Alkermes (ALKS) Operating Expenses (2010 - 2026)

Alkermes' (ALKS) quarterly Operating Expenses came in at $441.2 million in Q1 2026, up 50.72% year-on-year from $292.7 million in Q1 2025, and up 4934.7% on a QoQ basis from $8.8 million in Q4 2025.

Alkermes (ALKS) Operating Expenses (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Operating Expenses data on file, last reported at $441.2 million in Q1 2026.

  • On a quarterly basis, Operating Expenses rose 50.72% year-over-year to $441.2 million in Q1 2026; TTM through Mar 2026 was $760.9 million, a 32.22% decrease from a year earlier, with the FY2025 full-year figure at $12.3 million, down 98.92% from the prior year.
  • Operating Expenses for Q1 2026 stood at $441.2 million, up from $8.8 million in the prior quarter.
  • Over the last five years, Operating Expenses for ALKS reached as high as $441.2 million in Q1 2026 and fell as low as $5.4 million in Q1 2024.
  • Historically, Operating Expenses has averaged $250.4 million across 5 years, with a median of $292.7 million in 2025.
  • Across the five-year window, Operating Expenses sank 98.18% in 2024 and jumped 5300.7% in 2025, its largest moves.
  • Year by year, Operating Expenses stood at $189.1 million in 2022, then soared by 70.74% to $322.8 million in 2023, then declined by 17.21% to $267.3 million in 2024, then slumped by 96.72% to $8.8 million in 2025, then soared by 4934.7% to $441.2 million in 2026.
  • Per Business Quant data, the three most recent Operating Expenses figures were $441.2 million in Q1 2026, $8.8 million in Q4 2025, and $305.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 1.00 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 788.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 12.58 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 455.70 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 1.24 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 621.10 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 494.00 Mn
10 Alkermes 8.78 Bn 8.27 Bn 331.33 Mn 441.19 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 441.19 Mn
Dec 31, 2025 8.76 Mn
Sep 30, 2025 305.10 Mn
Jun 30, 2025 5.88 Mn
Mar 31, 2025 292.72 Mn
Dec 31, 2024 267.30 Mn
Sep 30, 2024 273.39 Mn
Jun 30, 2024 289.25 Mn
Mar 31, 2024 5.42 Mn
Dec 31, 2023 322.84 Mn
Sep 30, 2023 291.74 Mn
Jun 30, 2023 336.13 Mn
Mar 31, 2023 298.57 Mn
Dec 31, 2022 189.08 Mn
Sep 30, 2022 313.00 Mn
Jun 30, 2022 310.68 Mn
Mar 31, 2022 305.13 Mn
Dec 31, 2021 195.05 Mn
Sep 30, 2021 313.80 Mn
Jun 30, 2021 299.30 Mn